Vipul Drugs Private Limited, a active private limited company, was established on 10 December 1991 in Mumbai, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U22330MH1991PTC064375. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹2.00 Cr and a paid-up capital of ₹1.73 Cr.
It upholds a compliant status. Its leadership includes Vipul Navinchandra Mehta (Director), Samir Navinchandra Mehta (Director). Past directors included Navinchandra Mansukhlal Mehta. It holds no open charges and ₹14.50 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 202 Anandi Villalajpatrai Road Vile Parle (W), Mumbai, Maharashtra, 400056.
U22330MH1991PTC064375
064375
10 December 1991
₹2.00 Cr
₹1.73 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Vipul Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vipul Navinchandra Mehta | Director | 10 Dec 1991 | Current |
| Samir Navinchandra Mehta | Director | 18 Jun 1998 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 27 Nov 2015 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Vipul Drugs Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 99.95% decrease. The company also saw a substantial improvement in profitability, with a 60.7% increase in profit. The company's net worth dipped by a decrease of 4.79%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Vipul Drugs had a public holding of 12.08%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹145,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 12 Mar 2010 | Standard Chartered Bank | ₹5.50 Cr | Satisfied |
| 21 Feb 2003 | The Greater Bombay Co-Op Bank Ltd | ₹1.00 Cr | Satisfied |
| 12 Feb 2001 | The Grater Bank | ₹5.00 M | Satisfied |
| 12 Jan 2001 | The Grater Bank | ₹5.00 Cr | Satisfied |
| 03 Mar 2000 | The Grater Bank | ₹2.50 Cr | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Vipul Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Vipul Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vipul Drugs's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Vipul Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Vipul Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was recorded as a recent event.
Progress on A charge registered on 12 Mar 2010 via Charge ID 10211609 with Standard Chartered Bank was fully satisfied on 14 Jun 2012. was documented.
The activity A charge registered on 21 Feb 2003 via Charge ID 80010192 with The Greater Bombay Co-Op Bank Ltd was fully satisfied on 11 May 2010. was completed.
A charge with The Greater Bombay Co-Op Bank Ltd of Rs. 1.00 Cr registered on 21 Feb 2003 with Charge ID 80010192 was modified on 05 Apr 2010. was recorded as a recent event.
A charge registered on 12 Feb 2001 via Charge ID 90165401 with The Grater Bank was fully satisfied on 05 Apr 2010. was recorded as a recent event.
The CIN of Vipul Drugs Private Limited is U22330MH1991PTC064375.
Vipul Drugs Private Limited is headquartered at 202 Anandi Villalajpatrai Road Vile Parle (W), Mumbai, Maharashtra, 400056.
Vipul Drugs Private Limited was incorporated on 10 December 1991.
The current directors of Vipul Drugs Private Limited are
The primary industry of Vipul Drugs Private Limited is Trade.
Vipul Drugs Private Limited is unlisted.
The authorized capital of Vipul Drugs Private Limited is ₹2.00 Cr, and the paid-up capital is ₹1.73 Cr.
The compliance status of Vipul Drugs Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX